NAUT · Nautilus Biotechnology, Inc.
$0.95
+0.05 (+5.79%)
At close · Aug 21
Market Cap
$121.30M
Shares
127.08M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$59M
+16.6%
FY2025
Diluted EPS
-$0.47
+16.1%
FY2025
Operating Cash Flow
-$50.7M
+14.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $39.28M | $41.11M | $50.48M | $47.25M | $37.67M | $29.35M | $12.43M | |
| — | $25.73M | $31M | $28.9M | $25.95M | $21.15M | $3.31M | |
| $64.12M | $66.84M | $81.48M | $76.15M | $63.62M | $50.5M | $15.74M | |
| $7.03M | $7.84M | $10.7M | $12.48M | $5.69M | $183K | $125K | |
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| -$57.09M | -$59M | -$70.78M | -$63.68M | -$57.92M | -$50.32M | -$15.62M | |
| -$57.37M | -$58.82M | -$70.47M | -$62.08M | -$59.59M | -$50.5M | -$15.62M | |
| USD/shares | — | -$0.47 | -$0.56 | -$0.51 | -$0.46 | -$0.60 | -$0.54 |
| USD/shares | — | -$0.47 | -$0.56 | -$0.51 | -$0.46 | -$0.60 | -$0.54 |
| shares | — | 126.26M | 125.43M | 124.92M | 124.59M | 84.46M | 29.09M |
| shares | — | 126.26M | 125.43M | 124.92M | 124.59M | 84.46M | 29.09M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.28×
EV/EBIT
—
Peer median 10.95×
P/E (TTM)
—
Peer median 9.32×
Peer medians compare against the 305 similar-size Biotechnology companies (of 545 listed).
Key facts
CIK
1808805
CUSIP
63909J108
13F (30d)
86 filings
85 filers
Visit website
Investor relations